Purchase Order 75D30122P13511

Award Date 3/22/22
Potential Completion Date 4/15/22
Potential Value $180K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Castleton, IN 46256, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for MAGNA PURE KIT. The potential value of the contract is $118,665.00 and the completion date is March 31, 2022. Roche Diagnostics is a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract does...
This $90,000.00 firm fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation for MAGNA PURE 96 products. The contract has no set-aside designation and has a completion date of July 23, 2022. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. They have previously received prime contract and subcontract awards from various federal...
This firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the MAGNA PURE 96 INSTRUMENT IVD, with a ceiling value of $90,000.00 and a completion date of July 15, 2017. Roche Diagnostics has received numerous federal contract awards, including through its...
This federal contract award, with an ID of HHSD2002017M93189P, was made by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation for the procurement of a MAGNA PURE 96 INSTRUMENT WITH ACCESSORIES. The fixed-price contract has a ceiling value of $105,000.00 and an ultimate completion date of March 30, 2017. Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory...
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Roche Diagnostics Corporation for the MAGNA PURE 96 IVD INSTRUMENT. The contract has a ceiling value of $105,000.00 and an ultimate completion date of March 21, 2016. The contract is not designated as a set-aside. Roche Diagnostics Corporation is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the MAGNA PURE96 INSTRUMENT. The contract has a ceiling value of $91,563.00 and an ultimate completion date of August 31, 2017. The contract is not designated as a set-aside. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services to...
The Department of the Army Medical Command awarded a firm-fixed-price purchase order contract to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments, to provide a MAGNA PURE 96 INSTRUMENT IVD. The contract has a potential value of $194,000.00 and a completion date of January 11, 2021. This award was made through a special notice solicitation using simplified acquisition procedures and was not set aside for any...
This is a $97,000.00 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the acquisition of MAGNA PURE EQUIPMENT and does not have a set-aside designation. Roche Diagnostics has received multiple prime contract and subcontract awards from various federal agencies to provide...
This contract award to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory instruments, is for the provision of MAGNA PURE 96 IVD INSTRUMENT. The award, valued at $97,000.00, was made by the Bureau of Medicine and Surgery, a component of the Department of Defense, as part of the national response to the Coronavirus COVID-19 pandemic. The contract is a firm fixed-price purchase order with a completion date of June 5, 2020. Roche...
This federal contract award, valued at $90,000.00, was issued by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the delivery of a MAGNA PURE 96 INSTRUMENT and does not have a set-aside designation. Roche Diagnostics has previously received prime contract and subcontract awards from various federal agencies,...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the delivery of MAGNA PURE 96 INSTRUMENTS. The contract, which has a potential value of $180,000.00, does not have a set-aside designation and has an anticipated completion date of April 15, 2022. Roche Diagnostics, a foreign-owned, for-profit manufacturer of in vitro diagnostics, laboratory instruments, and associated products and services, has previously received prime and subcontract awards from various federal agencies, including the Department of Veterans Affairs, Department of Defense, and Department of Health and Human Services, to provide critical care analyzers, reagents, test kits, and other medical equipment and supplies. The award to Roche Diagnostics appears to be part of the agency's efforts to acquire essential laboratory instrumentation and consumables to support its public health and disease control mission.

Generated 3/22/24, 5:39 PM